PharmaBoardroom

Hungary’s National Champions Betting on Biosimilars

Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European…

Drug Shortages Hitting Hungary Hard

Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most…

Data for Safer Care: AI in Healthcare-Associated Infections

Awareness is growing of the dangers of healthcare-associated infections (HAIs) in Europe, and conversations are beginning to taking place around how…

Hungary: Falling Behind for Innovative Medicines

Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria…

UAE Pharma’s First Steps into North America

LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with Canada’s Apotex to produce 120 million…

Stanley Huang – Founder & Managing Director, Nutrarex…

Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively representing a number of cutting-edge raw…

Central & Eastern Europe Pharma Market Snapshot

Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of EUR 6.352 billion for 2017. The Czech…

Christoph Stoller of Medicines for Europe on Tackling Drug…

Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide…

Oncology Care in Hungary: In Need of Reform

Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country's innovative pharma association has…